-DNA   Muzaffarpur (Bihar): Some 30 kms away from Bihar's Muzaffarpur, in Moshari block, peasants sit around a common hookah at a village chaupal after an exhausting day. They sign Maithili folk songs and relating stories of Raj Kishore and Tasleemudin, legendary Naxalite leaders who took on local landlords in the 1960s. This region, along with Naxalbari in neighbouring West Bengal, was the centre of bloody clashes, forcing socialist leader Jai Prakash Narayan...

-Down to Earth Grand old party of India renews some old promises and makes some new ones, but will Congress live up to its promises if it wins a third term? The Indian National Congress (INC) presented its manifesto for the upcoming Lok Sabha elections on Wedneday. The manifesto committee claimed the 48-page document was prepared after wide consultations by engaging millions of people, grassroots congress workers and every section of the...

-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...

-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...